Health Care: Drugs

Orexigen Therapeutics Inc (OREX: NASDAQ)

$0.4301 0.0198 | 4.83%
06/28/16 - 03:59 PM ET
Company Income Statement
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Sales 24.46M 55.52M 3.43M 3.43M
Cost of Sales 0.00 0.00 0.00 0.00
Gross Operating Profit 24.46M 55.52M 3.43M 3.43M
Selling, General, and Administrative Expenses 43.76M 28.64M 23.88M 19.99M
Research & Development 40.75M 57.41M 56.75M 73.68M
Operating Income before D & A (EBITDA) -60.05M -30.53M -77.20M -90.24M
Depreciation & Amortization 5.25M 4.81M 1.23M 813.00K
Interest Income 227.00K 88.00K 65.00K 147.00K
Other Income - Net -39.00K 0.00 0.00 0.00
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -65.12M -35.25M -78.36M -90.91M
Interest Expense 7.45M 7.08M 538.00K 2.00K
Pre-Tax Income -72.56M -42.34M -78.90M -90.91M
Income Taxes 1.38M 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -68.69M -37.52M -77.67M -90.09M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -68.69M -37.52M -77.67M -90.09M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -68.69M -37.52M -77.67M -90.09M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-68.69M -37.52M -77.67M -90.09M
Preferred Dividends
Net Income Available To Common -68.69M -37.52M -77.67M -90.09M
Basic EPS from Continuing Ops. -0.52 -0.32 -0.80 -1.27
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.52 -0.32 -0.80 -1.27
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.52 -0.32 -0.80 -1.27
Basic Normalized Net Income/Share -0.52 -0.32 -0.80 -1.27
EPS fr Continuing Ops. -0.52 -0.32 -0.80 -1.27
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.52 -0.32 -0.80 -1.27
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.52 -0.32 -0.80 -1.27
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.52 -0.32 -0.80 -1.27
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with OREX

Latest OREX Headlines from TheStreet

More Financial News for OREX

Press Releases for OREX

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter